• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫原性细胞死亡:概念与治疗意义。

Immunogenic cell death in cancer: concept and therapeutic implications.

机构信息

Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.

Sandra and Edward Meyer Cancer Center, New York, NY, USA.

出版信息

J Transl Med. 2023 Mar 2;21(1):162. doi: 10.1186/s12967-023-04017-6.

DOI:10.1186/s12967-023-04017-6
PMID:36864446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979428/
Abstract

Mammalian cells responding to specific perturbations of homeostasis can undergo a regulated variant of cell death that elicits adaptive immune responses. As immunogenic cell death (ICD) can only occur in a precise cellular and organismal context, it should be conceptually differentiated from instances of immunostimulation or inflammatory responses that do not mechanistically depend on cellular demise. Here, we critically discuss key conceptual and mechanistic aspects of ICD and its implications for cancer (immuno)therapy.

摘要

哺乳动物细胞对稳态的特定扰动做出反应,可以经历一种受调控的细胞死亡变体,从而引发适应性免疫反应。由于免疫原性细胞死亡(ICD)只能在特定的细胞和机体环境中发生,因此应该与那些在机制上不依赖于细胞死亡的免疫刺激或炎症反应区分开来。在这里,我们批判性地讨论了 ICD 的关键概念和机制方面及其对癌症(免疫)治疗的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/9979428/a31c8c9b5ce6/12967_2023_4017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/9979428/a31c8c9b5ce6/12967_2023_4017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39a8/9979428/a31c8c9b5ce6/12967_2023_4017_Fig1_HTML.jpg

相似文献

1
Immunogenic cell death in cancer: concept and therapeutic implications.肿瘤免疫原性细胞死亡:概念与治疗意义。
J Transl Med. 2023 Mar 2;21(1):162. doi: 10.1186/s12967-023-04017-6.
2
Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.海洋来源天然化合物作为免疫原性细胞死亡(ICD)诱导剂:在癌症阻断和治疗中的潜在作用。
Cells. 2021 Jan 25;10(2):231. doi: 10.3390/cells10020231.
3
Molecular determinants of immunogenic cell death elicited by radiation therapy.放疗诱导免疫原性细胞死亡的分子决定因素。
Immunol Rev. 2024 Jan;321(1):20-32. doi: 10.1111/imr.13271. Epub 2023 Sep 7.
4
Trial watch: chemotherapy-induced immunogenic cell death in oncology.研究动态:肿瘤治疗中的化疗诱导免疫原性细胞死亡
Oncoimmunology. 2023 Jun 3;12(1):2219591. doi: 10.1080/2162402X.2023.2219591. eCollection 2023.
5
Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.基于纳米颗粒的免疫原性细胞死亡诱导剂和免疫检查点抑制剂的联合癌症免疫疗法。
Int J Nanomedicine. 2021 Feb 22;16:1435-1456. doi: 10.2147/IJN.S285999. eCollection 2021.
6
Immunogenic cell stress and death.免疫原性细胞应激和死亡。
Nat Immunol. 2022 Apr;23(4):487-500. doi: 10.1038/s41590-022-01132-2. Epub 2022 Feb 10.
7
Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.免疫原性细胞死亡:胃肠道癌症的一个新靶点。
Cells. 2022 Sep 28;11(19):3033. doi: 10.3390/cells11193033.
8
Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.放疗诱导免疫原性细胞死亡的生物标志物。
Cells. 2021 Apr 17;10(4):930. doi: 10.3390/cells10040930.
9
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.试验观察:免疫肿瘤学中化疗诱导的免疫原性细胞死亡
Oncoimmunology. 2020 Jan 9;9(1):1703449. doi: 10.1080/2162402X.2019.1703449. eCollection 2020.
10
Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.免疫原性细胞死亡和免疫检查点阻断治疗的机制。
Kaohsiung J Med Sci. 2021 Jun;37(6):448-458. doi: 10.1002/kjm2.12375. Epub 2021 Feb 26.

引用本文的文献

1
Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses.病毒战:释放工程化溶瘤病毒以智取癌症防御。
Front Immunol. 2025 Aug 25;16:1618751. doi: 10.3389/fimmu.2025.1618751. eCollection 2025.
2
Inflammatory mitochondrial signalling and viral mimicry in cancer.癌症中的炎症性线粒体信号传导与病毒模拟
J Transl Med. 2025 Sep 2;23(1):982. doi: 10.1186/s12967-025-06931-3.
3
Plant programmed cell death in the context of diversity and evolution of PCD.在细胞程序性死亡的多样性与进化背景下的植物程序性细胞死亡

本文引用的文献

1
Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis.三氧化二砷通过诱导坏死性凋亡和铁死亡引发针对实体瘤的预防和治疗性免疫应答。
Cell Mol Immunol. 2023 Jan;20(1):51-64. doi: 10.1038/s41423-022-00956-0. Epub 2022 Nov 30.
2
Combined atezolizumab and nab-paclitaxel in the treatment of triple negative breast cancer: a meta-analysis on their efficacy and safety.阿替利珠单抗联合白蛋白紫杉醇治疗三阴性乳腺癌的疗效及安全性的Meta 分析
BMC Cancer. 2022 Nov 5;22(1):1139. doi: 10.1186/s12885-022-10225-y.
3
Autophagy-inducing nutritional interventions in experimental and clinical oncology.
Protoplasma. 2025 Aug 15. doi: 10.1007/s00709-025-02102-9.
4
Metal-based nanomedicines for cancer theranostics.用于癌症诊疗的金属基纳米药物。
Mil Med Res. 2025 Jul 30;12(1):41. doi: 10.1186/s40779-025-00627-x.
5
The dark matter in cancer immunology: beyond the visible- unveiling multiomics pathways to breakthrough therapies.癌症免疫学中的暗物质:超越可见——揭示通向突破性疗法的多组学途径。
J Transl Med. 2025 Jul 22;23(1):808. doi: 10.1186/s12967-025-06839-y.
6
Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer.帕博利珠单抗与放疗联合可在免疫冷型非小细胞肺癌中诱导全身抗肿瘤免疫反应。
Nat Cancer. 2025 Jul 22. doi: 10.1038/s43018-025-01018-w.
7
Identification of a novel ferroptosis-induced immunogenic cell death related signature based on a machine learning framework in colorectal cancer.基于机器学习框架鉴定结直肠癌中一种新型铁死亡诱导的免疫原性细胞死亡相关特征。
Discov Oncol. 2025 Jul 9;16(1):1289. doi: 10.1007/s12672-025-03147-1.
8
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a "Brakes Off/ Step on the Accelerator" Core-Shell Manganese Phosphate/siPD-L1 Modulator.基于“松开刹车/踩下油门”核壳型磷酸锰/硅基程序性死亡受体1配体调节剂对肿瘤微环境进行双向重编程的癌症免疫疗法
Exploration (Beijing). 2025 Feb 9;5(3):270009. doi: 10.1002/EXP.70009. eCollection 2025 Jun.
9
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects.树突状细胞衍生的外泌体作为无细胞抗癌剂:增强免疫原性作用的新见解
Front Immunol. 2025 May 28;16:1586892. doi: 10.3389/fimmu.2025.1586892. eCollection 2025.
10
CYPD limits HR mammary carcinogenesis in mice.CYPD限制小鼠的人源化乳腺致癌作用。
Cell Death Discov. 2025 Jun 10;11(1):273. doi: 10.1038/s41420-025-02555-0.
自噬诱导的营养干预在实验和临床肿瘤学中的应用。
Int Rev Cell Mol Biol. 2022;373:125-158. doi: 10.1016/bs.ircmb.2022.08.003. Epub 2022 Sep 26.
4
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes.PDIA3 表位驱动的免疫自身反应导致 2 型糖尿病肝损伤。
Sci Immunol. 2022 Aug 12;7(74):eabl3795. doi: 10.1126/sciimmunol.abl3795. Epub 2022 Aug 19.
5
Schweinfurthin induces ICD without ER stress and caspase activation.舒芬太尼诱导 ICD 不依赖内质网应激和半胱天冬酶激活。
Oncoimmunology. 2022 Aug 3;11(1):2104551. doi: 10.1080/2162402X.2022.2104551. eCollection 2022.
6
Caspase Activation and Inhibition.半胱天冬酶的激活与抑制
Cold Spring Harb Perspect Biol. 2022 Aug 1;14(8):a041020. doi: 10.1101/cshperspect.a041020.
7
PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer.PD-1 阻断与基于奥沙利铂的化疗联合应用具有协同作用,而非基于顺铂的化疗。
Oncoimmunology. 2022 Jun 24;11(1):2093518. doi: 10.1080/2162402X.2022.2093518. eCollection 2022.
8
Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade.常规两性霉素 B 可诱导白血病细胞发生免疫原性细胞死亡,介导吞噬细胞的免疫刺激作用,并与 PD-L1 阻断协同作用。
Oncoimmunology. 2022 Apr 25;11(1):2068109. doi: 10.1080/2162402X.2022.2068109. eCollection 2022.
9
A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients.一个功能丧失的多态性降低了头颈部癌患者的治疗效果。
Oncoimmunology. 2022 Apr 17;11(1):2059878. doi: 10.1080/2162402X.2022.2059878. eCollection 2022.
10
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.B 细胞和三级淋巴结构作为肿瘤免疫微环境和临床结局的决定因素。
Nat Rev Clin Oncol. 2022 Jul;19(7):441-457. doi: 10.1038/s41571-022-00619-z. Epub 2022 Apr 1.